TGFB1 and pulmonary fibrosis: In a negative feedback loop, Smad7 inhibits TGF-β signaling by competing for the TGF-β type 1 receptor, blocking phosphorylation and activation of Smad2 and thus preventing pulmonary fibrosis [434].